Table 1 Main baseline participants’ criteria:
Baseline criteria for eligible population | Value | |||
|---|---|---|---|---|
Demographic criteria | ||||
• Age (years) | Mean (SD) | 58 | (9.1) | |
• Sex | • Male | Count (%) | 160 | (64%) |
• Female | Count (%) | 90 | (36%) | |
• Total | Count (%) | 250 | (100%) | |
Patients clinical criteria | ||||
• Presentation | • Hematemesis | Count (%) | 52 | 21% |
• Melena | Count (%) | 37 | 15% | |
• Combined hematemesis and melena | Count (%) | 161 | 64% | |
• Previous variceal bleeding | Count (%) | 105 | 42% | |
• Variceal grading | • Grade 1 | Count (%) | 10 | 4% |
• Grade 2 | Count (%) | 102 | 41% | |
• Grade 3 | Count (%) | 138 | 55% | |
• Variceal bleeding control | • EBL | Count (%) | 42 | 17% |
• EIT | Count (%) | 208 | 83% | |
• Need for blood transfusion | Count (%) | 163 | 65% | |
• Ascites | • No ascites | Count (%) | 33 | (13.2%) |
• Mild to moderate | Count (%) | 141 | (56.4%) | |
• Massive | Count (%) | 76 | (30.4%) | |
• Spleen diameter (cm) | Median (IQR) | 15 | (3) | |
• HCC | Count (%) | 22 | (9%) | |
• Etiology of cirrhosis | • CHC | Count (%) | 196 | (78.4%) |
• CHB | Count (%) | 21 | (8.4%) | |
• CHC and CHB | Count (%) | 9 | (3.6%) | |
• Other | Count (%) | 24 | (9.6%) | |
Laboratory parameters | ||||
• ALT (IU/L) | Mean (SD) | 43.3 | (11.66) | |
• AST (IU/L) | Mean (SD) | 47.6 | (10.73) | |
• S. albumin (gm/l) | Mean (SD) | 28.9 | (3.42) | |
• S. bilirubin (mg/dl) | Median (IQR) | 2.5 | (1.4) | |
• INR | Median (IQR) | 2.1 | (0.30) | |
• S. creatinine (mg/dl) | Median (IQR) | 1.2 | (0.2) | |
• Platelets (×103/mm3) | Median (IQR) | 145 | (54) | |
• Hemoglobin (g/dl) | Median (IQR) | 9.6 | (0.9) | |
Evaluated scores for liver functions | ||||
• Child-Pugh score | Median (IQR) | 10 | (3) | |
• MELD score | Median (IQR) | 19.8 | (4.4) | |
• ALBI score | Median (IQR) | -1.4 | (0.6) | |
• ALBI grade | • ALBI grade 1 | Count (%) | 0 | (0%) |
• ALBI grade 2 | Count (%) | 118 | (47.2%) | |
• ALBI grade 3 | Count (%) | 132 | (52.8%) | |